1-Ethyl-3-methylimidazolium tosylate

We are 1-Ethyl-3-methylimidazolium tosylate CAS:328090-25-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-Ethyl-3-methylimidazolium tosylate
Synonyms:1-ethyl-3-methylimidazol-3-ium,4-methylbenzenesulfonate
Molecular Formula: C13H18N2O3S
Molecular Weight: 282.36
CAS No.: 328090-25-1
Purity: 99%
 
Technical Information

Appearance: Purity:
NMR: Passed null
Solubility: Insolubility:
Impurity content: (1)Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: 49.78℃ Decomposition temperature:
Conductivity: Electrochemical window:
Viscosity: Density: 1.21g/cm3

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
 1-Ethyl-3-methylimidazolium tosylate


Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.838-07-3 The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.38916-34-6 Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.Nesiritide acetate CAS:114471-18-0 Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.

Related Products
Product Name
3-Amino-2-hydroxy-5-nitrobenzenesulfonic Acid View Details
1-Bromoheptane View Details
N-Boc-glycine Ethyl Ester View Details
CAS:68937-41-7 Isopropylate phenyl Diphenyl Phosphate manufacturer 5-nitro-2,3-dihydro-1-benzofuran manufacturer 2-Chloro-6-fluorotoluene manufacturer 2-Fluoro-4-nitrotoluene manufacturer 2-Nitroaminoimidazoline manufacturer